JPM jump

Gainers, decliners in the wake of 2017 JPMorgan Healthcare Conference

Nine of the 160 biotechs that presented at the 2017 JPMorgan Healthcare Conference not only skated through the volatile week unharmed, but managed to post gains of at least 15%, with Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) leading all risers after Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) announced that it

Read the full 475 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE